<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: A Risk-Based Approach To Monitoring of Clinical Investigations: Questions and Answers; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: A Risk-Based Approach To Monitoring of Clinical Investigations: Questions and Answers; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2019-03-15 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "A Risk- Based Approach to Monitoring of Clinical Investigations: Questions and Answers." The draft guidance provides information to sponsors on risk- based approaches to monitoring of investigational studies of human drug and biological products, medical devices, and combinations thereof. This guidance expands on the guidance for industry entitled "Oversight of Clinical Inve...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2019-04814</p>
    <p><strong>Publication Date:</strong> 2019-03-15</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/03/15/2019-04814/a-risk-based-approach-to-monitoring-of-clinical-investigations-questions-and-answers-draft-guidance">https://www.federalregister.gov/documents/2019/03/15/2019-04814/a-risk-based-approach-to-monitoring-of-clinical-investigations-questions-and-answers-draft-guidance</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-04814</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
